Detection of Chemotherapy Induced Cardiotoxicity

Completed

Conditions studied: Cancer

In brief

To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).

Key facts

Study ID

NCT00636844

Run by

George Washington University

People needed

36

Starts

2008-01-01

Expected to finish

2012-06-01

Last updated by the study team

2013-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• undergoing anthracycline and/or trastuzumab therapy for the first time

You may not qualify if…

• abnormal ventricular ejection fraction
• past history of, or active cardiac disease including: MI, CHF, angina, arrhythmia requiring medication, valvular disease, uncontrolled systemic hypertension

Where it is running

• George Washington University — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.